Your browser doesn't support javascript.
loading
A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers.
Diab, Adi; Hamid, Omid; Thompson, John A; Ros, Willeke; Eskens, Ferry A L M; Doi, Toshihiko; Hu-Lieskovan, Siwen; Klempner, Samuel J; Ganguly, Bishu; Fleener, Catherine; Wang, Xiao; Joh, Tenshang; Liao, Ken; Salek-Ardakani, Shahram; Taylor, Carrie Turich; Chou, Jeffrey; El-Khoueiry, Anthony B.
Afiliación
  • Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ADiab@mdanderson.org.
  • Hamid O; Immuno-Oncology and Cutaneous Malignancies, The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, California.
  • Thompson JA; Division of Medical Oncology, University of Washington School of Medicine/Seattle Cancer Care Alliance, Seattle, Washington.
  • Ros W; Department of Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Eskens FALM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Doi T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Hu-Lieskovan S; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles (UCLA), Los Angeles, California.
  • Klempner SJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Ganguly B; Pfizer, New York, New York.
  • Fleener C; Pfizer, New York, New York.
  • Wang X; Pfizer, New York, New York.
  • Joh T; Pfizer, New York, New York.
  • Liao K; Pfizer, New York, New York.
  • Salek-Ardakani S; Pfizer, New York, New York.
  • Taylor CT; Pfizer, New York, New York.
  • Chou J; Pfizer, New York, New York.
  • El-Khoueiry AB; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.
Clin Cancer Res ; 28(1): 71-83, 2022 01 01.
Article en En | MEDLINE | ID: mdl-34615725
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article